TIMI risk score, characteristics and risk of 30-day mortality.

<p>MI indicates myocardial infarction, LBB, left bundle branch block, HPT, hypertension.</p><p>Other variables adjusted in the model: never smoked, prior MI, peripheral arterial disease, anti-arrhythmic medication, lipid lowering drugs and female sex.</p>*<p>obtained from Morrow et al (6).</p>**<p>Diabetes, HPT and prior angina combined has a risk score of 1.</p

Baseline characteristics of patient populations from TIMI Score development set and study set.

<p>Data are % for categorical variables and median (interquartile range) for continuous variables.</p><p>CAD, coronary artery disease, HPT, hypertension, LBB, left bundle branch block.</p><p>NA, not available/not applicable.</p

Percentage at risk by the TIMI risk score for the TIMI risk score development population, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.

<p>Percentage at risk by the TIMI risk score for the TIMI risk score development population, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.</p

Mortality rate at 30 days for the TIMI risk score development, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.

<p>Mortality rate at 30 days for the TIMI risk score development, Malaysian STEMI population, as well as diabetic (DM) and renal impairment sub-groups.</p

Additional file 2: of Effectiveness of the EMPOWER-PAR Intervention in Improving Clinical Outcomes of Type 2 Diabetes Mellitus in Primary Care: A Pragmatic Cluster Randomised Controlled Trial

Definition of outcome categories at 1-year follow-up (PDF 230 kb